Association Analysis of ABCC4 Gene Polymorphism with the Therapeutic Effect of Glucocorticoid in ITP Patients

XU Yan-mei,ZHANG Jing,LI Jing,HUANG Bo,LIU Jing,LIN Jin,WANG Yan,YANG Weiming,MIN Qinghua,WANG Xiaozhong

DOI: https://doi.org/10.3969/j.issn.1674-1129.2016.01.003

2016-01-01

Abstract:Objective To explore the association of ABCC4 rs10508022 gene single nucleotide polymorphism with glucocorti-coid therapeutic effect in ITP patients. Methods Seventy-five hospitalized patients diagnosed with ITP were collected from June 2013 to June 2015 in our hospital as case group,of which 46 patients were sensitive to glucocorticoid and remains were resistant to glucocorticoid. 60 healthy subjects were collected from the same period as control group. The gene typing of rs10508022 was performed by SNaPshot method. And the correlation between rs10508022 and the effect of glucocorticoid therapy in ITP patients was estimated. Results The genotype distribution of rs10508022 had no statistical difference (P=0.15) between cases and controls, but had significant difference in the sensitive and resistant group for glucocorticoid in ITP patients (P=0.003). And Gallele was the risk allele for glucocorticoid resistance in ITP (OR=3.17,95%CI=1.55-6.47). Conclusions ABCC4 gene polymorphism is associ-ated with the glucocorticoid resistant in ITP patients,and G allele may be the risk allele.